๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors

โœ Scribed by Erich Brendel; Matthias Ludwig; Chetan Lathia; Caroline Robert; Stanislas Ropert; Jean-Charles Soria; Jean-Pierre Armand

Publisher
Springer
Year
2010
Tongue
English
Weight
367 KB
Volume
68
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I clinical trial of bortezomib in
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
โœ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and doseโ€limiting toxicities (DLTs) of bortezomib in combi